Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the
Company’s Board of Directors has declared a quarterly cash dividend of
US$0.09 per share payable on January 4, 2010 to shareholders of record
at the close of business December 2, 2009. The ex-dividend date is
November 30, 2009.
Important Income-Tax Information for Canadian Resident Shareholders
Biovail Corporation designates the entire amount of this taxable
dividend to be an “eligible dividend” for purposes of the Income Tax Act
(Canada), as amended from time to time. This notice meets the
requirements of the Income Tax Act (Canada). Please contact your tax
advisor if you have any questions with regard to the designation of the
eligible dividend.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the
formulation, clinical testing, registration, manufacture, and
commercialization of pharmaceutical products. The Company is focused on
the development and commercialization of medicines that address unmet
medical needs in niche specialty central nervous system (CNS) markets.
For more information about Biovail, visit the Company’s Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000
or send inquiries to ir@biovail.com.
(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
